Healthcare101

  AI in Precision Medicine Market worth $3.92 billion by 2030 The report “ AI in Precision Medicine Market by Application (Drug Discovery, Screening, Diagnosis, Stratification, Staging, Prognosis, Therapy Selection, Monitoring, Risk Management), Indication (Cancer, CNS, CVS), Tools (ML, NLP), & End User -Global Forecast to 2030” , is projected to reach USD 3.92 billion by 2030 from USD 0.78 billion in 2024, at a CAGR of 30.7% from 2024 to 2030. Several factors propelling the expansion of AI technologies in precision medicine are in tune with the availability of advanced technologies and the rising need for personalized patient care. To begin with, there is a massive collection of data types in terms of genomics, proteomics, and metabolomics, which AI performs and extracts disease biomarkers and variants. For instance, Google’s DeepVariant can optimize genomic sequencing accuracy with the power of AI, facilitating targeted treatment models. Additionally, there is also a tr...

 The global AI in precision medicine market is projected to reach USD 3.92 billion by 2030 from USD 0.78 billion in 2024, at a CAGR of 30.7% from 2024  to 2030. The major factors driving the growth of the AI in precision medicine market include rapidly increasing need for more customized treatments, improvement in genomics and multi-omics technologies, and a drive to accelerate drug development is driving advances in AI in precision medicine. The ability of AI to analyse such complex biological and clinical data thus allows quicker identification of mechanisms for the disease as well as tailored therapies. Additionally, factors such as increasing costs of healthcare and failures of traditional approaches pave the way for embracing AI in an aim to optimize diagnostic procedures, advance the methodologies of treatment, and elevate patient outcomes. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=153786351 Browse in-depth TOC on "AI in Precis...